{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:40:04Z","timestamp":1789674004982,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      PTEN hamartoma syndrome (PHTS) is an autosomal dominant disorder characterized by pathogenic variants in the tumor suppressor gene phosphatase and tensin homolog (\n                      <jats:italic>PTEN<\/jats:italic>\n                      ). It is associated with an increased risk of muco-cutaneous features, hamartomatous tumors, and cancers. Mosaicism has been found in a few cases of patients with de novo PHTS, identified from blood samples. We report a PHTS patient with no variant identified from blood sample. Constitutional PTEN mosaicism was detected through sequencing of DNA from different tumoral and non-tumoral samples.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      Our patient presented clinical Cowden syndrome at 56\u00a0years of age, with three major criteria (macrocephaly, Lhermitte Duclos disease, oral papillomatosis), and two minor criteria (structural thyroid lesions, esophageal glycogenic acanthosis). Deep sequencing of\n                      <jats:italic>PTEN<\/jats:italic>\n                      of blood leukocytes did not reveal any pathogenic variants. Exploration of tumoral (colonic ganglioneuroma, esophageal papilloma, diapneusia fibroids) and non-tumoral stomach tissues found the same\n                      <jats:italic>PTEN<\/jats:italic>\n                      pathogenic variant (NM_000314.4 c.389G\u2009&gt;\u2009A; p.(Arg130Gln)), with an allelic frequency of 12 to 59%, confirming genomic mosaicism for Cowden syndrome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This case report, and review of the literature, suggests that systematic tumor analysis is essential for patients presenting\n                      <jats:italic>PTEN<\/jats:italic>\n                      hamartoma syndrome in the absence of any causal variant identified in blood leukocytes, despite deep sequencing. In 65 to 70% of cases of clinical Cowden syndrome, no pathogenic variant in the\n                      <jats:italic>PTEN<\/jats:italic>\n                      is observed in blood samples: mosaicism may explain a significant number of these patients. Tumor analysis would improve our knowledge of the frequency of de novo variations in this syndrome. Finally, patients with mosaicism for\n                      <jats:italic>PTEN<\/jats:italic>\n                      may not have a mild phenotype; medical care identical to that of heterozygous carriers should be offered.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-023-01600-0","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T05:01:48Z","timestamp":1689224508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diagnosis of PTEN mosaicism: the relevance of additional tumor DNA sequencing. A case report and review of the literature"],"prefix":"10.1186","volume":"16","author":[{"given":"Mathias","family":"Cavaill\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Crampon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viorel","family":"Achim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Bubien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Uhrhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Privat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Ponelle-Chachuat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Gay-Bellile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathis","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zangb\u00e9wend\u00e9 Guy","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Bidet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sevenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves-Jean","family":"Bignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"issue":"11","key":"1600_CR1","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/ejhg.2008.162","volume":"16","author":"GM Blumenthal","year":"2008","unstructured":"Blumenthal GM, Dennis PA. PTEN hamartoma tumor syndromes. Eur J Hum Genet. 2008;16(11):1289\u2013300.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"1600_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10897-008-9187-7","volume":"18","author":"R Pilarski","year":"2009","unstructured":"Pilarski R. Cowden syndrome: a critical review of the clinical literature. J Genet Couns f\u00e9vr. 2009;18(1):13\u201327.","journal-title":"J Genet Couns f\u00e9vr"},{"issue":"9","key":"1600_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/jmg.2007.049981","volume":"44","author":"KL Lachlan","year":"2007","unstructured":"Lachlan KL, Lucassen AM, Bunyan D, Temple IK. Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet sept. 2007;44(9):579\u201385.","journal-title":"J Med Genet sept"},{"issue":"5","key":"1600_CR4","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1086\/379382","volume":"73","author":"XP Zhou","year":"2003","unstructured":"Zhou XP, Marsh DJ, Morrison CD, Chaudhury AR, Maxwell M, Reifenberger G, et al. Germline Inactivation of PTEN and dysregulation of the Phosphoinositol-3-Kinase\/Akt pathway cause human Lhermitte-Duclos disease in adults. Am J Hum Genet. 2003;73(5):1191\u20138.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"1600_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/sj.ejhg.5201823","volume":"15","author":"F Caux","year":"2007","unstructured":"Caux F, Plauchu H, Chibon F, Faivre L, Fain O, Vabres P, et al. Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity. Eur J Hum Genet juill. 2007;15(7):767\u201373.","journal-title":"Eur J Hum Genet juill"},{"issue":"4","key":"1600_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/jmg.2004.024646","volume":"42","author":"M Butler","year":"2005","unstructured":"Butler M, Dasouki M, Zhou X, Talebizadeh Z, Brown M, Takahashi T, et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet avr. 2005;42(4):318\u201321.","journal-title":"J Med Genet avr"},{"issue":"1","key":"1600_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/jnci\/djac188","volume":"115","author":"LAJ Hendricks","year":"2023","unstructured":"Hendricks LAJ, Hoogerbrugge N, Mensenkamp AR, Brunet J, Lleuger-Pujol R, H\u00f8berg-Vetti H, et al. Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome. J Natl Cancer Inst. 2023;115(1):93\u2013103.","journal-title":"J Natl Cancer Inst"},{"key":"1600_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ymeth.2014.10.011","volume":"77\u201378","author":"J Ngeow","year":"2015","unstructured":"Ngeow J, Eng C. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol. Methods mai. 2015;77\u201378:11\u20139.","journal-title":"Methods mai"},{"issue":"2","key":"1600_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","volume":"18","author":"MH Tan","year":"2012","unstructured":"Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res. 2012;18(2):400\u20137. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2283.","journal-title":"Clin Cancer Res"},{"issue":"21","key":"1600_CR10","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/jnci\/djt277","volume":"105","author":"R Pilarski","year":"2013","unstructured":"Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst. 2013;105(21):1607\u201316.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1600_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/jmedgenet-2012-101339","volume":"50","author":"V Bubien","year":"2013","unstructured":"Bubien V, Bonnet F, Brouste V, Hoppe S, Barouk-Simonet E, David A, et al. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet avr. 2013;50(4):255\u201363.","journal-title":"J Med Genet avr"},{"issue":"6","key":"1600_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/cancers11060844","volume":"11","author":"R Pilarski","year":"2019","unstructured":"Pilarski R. PTEN Hamartoma tumor syndrome: a clinical overview. Cancers (Basel). 2019;11(6):844.","journal-title":"Cancers (Basel)."},{"key":"1600_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41431-022-01052-7","volume":"30","author":"P Rofes","year":"2022","unstructured":"Rofes P, Teul\u00e9 \u00c1, Feliubadal\u00f3 L, Salinas M, Cuesta R, Iglesias S, et al. Mosaicism in PTEN\u2014new case and comment on the literature. Eur J Hum Genet. 2022;30:1\u20134.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"1600_CR14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/ejhg.2013.164","volume":"22","author":"J Steffann","year":"2014","unstructured":"Steffann J, Michot C, Borghese R, Baptista-Fernandes M, Monnot S, Bonnefont JP, et al. Parental mosaicism is a pitfall in preimplantation genetic diagnosis of dominant disorders. Eur J Hum Genet. 2014;22(5):711\u20132.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"1600_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/cge.12078","volume":"84","author":"A Gammon","year":"2013","unstructured":"Gammon A, Jasperson K, Pilarski R, Prior T, Kuwada S. PTEN mosaicism with features of Cowden syndrome. Clin Genet. 2013;84(6):593\u20135.","journal-title":"Clin Genet"},{"issue":"12","key":"1600_CR16","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/gim.2013.51","volume":"15","author":"CC Pritchard","year":"2013","unstructured":"Pritchard CC, Smith C, Marushchak T, Koehler K, Holmes H, Raskind W, et al. A mosaic PTEN mutation causing Cowden syndrome identified by deep sequencing. Genet Med d\u00e9c. 2013;15(12):1004\u20137.","journal-title":"Genet Med d\u00e9c"},{"issue":"3","key":"1600_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10689-014-9709-4","volume":"13","author":"EE Salo-Mullen","year":"2014","unstructured":"Salo-Mullen EE, Shia J, Brownell I, Allen P, Girotra M, Robson ME, et al. Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome. Familial Cancer. 2014;13(3):459\u201367.","journal-title":"Familial Cancer"},{"issue":"7","key":"1600_CR18","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/ajmg.a.61166","volume":"179","author":"MM Golas","year":"2019","unstructured":"Golas MM, Auber B, Ripperger T, Pabst B, Schmidt G, Morlot M, et al. Looking for the hidden mutation: Bannayan\u2013Riley\u2013Ruvalcaba syndrome caused by constitutional and mosaic 10q23 microdeletions involving PTEN and BMPR1A. Am J Med Genet A. 2019;179(7):1383\u20139.","journal-title":"Am J Med Genet A"},{"key":"1600_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s40478-019-0841-0","volume":"7","author":"A Goldenberg","year":"2019","unstructured":"Goldenberg A, Marguet F, Gilard V, Cardine AM, Hassani A, Doz F, et al. Mosaic PTEN alteration in the neural crest during embryogenesis results in multiple nervous system hamartomas. Acta Neuropathol Commun. 2019;7:191.","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"1600_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104533","volume":"65","author":"LAJ Hendricks","year":"2022","unstructured":"Hendricks LAJ, Schuurs-Hoeijmakers J, Spier I, Haadsma ML, Eijkelenboom A, Cremer K, et al. Catch them if you are aware: PTEN postzygotic mosaicism in clinically suspicious patients with PTEN Hamartoma Tumour syndrome and literature review. Eur J Med Genet juill. 2022;65(7): 104533.","journal-title":"Eur J Med Genet juill"},{"key":"1600_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/fgene.2018.00353","volume":"9","author":"M Cavaill\u00e9","year":"2018","unstructured":"Cavaill\u00e9 M, Ponelle-Chachuat F, Uhrhammer N, Viala S, Gay-Bellile M, Privat M, et al. Early onset multiple primary tumors in atypical presentation of Cowden syndrome identified by whole-exome-sequencing. Front Genet. 2018;9:353.","journal-title":"Front Genet"},{"issue":"9","key":"1600_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/gim.2012.51","volume":"14","author":"J Mester","year":"2012","unstructured":"Mester J, Eng C. Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome. Genet Med sept. 2012;14(9):819\u201322.","journal-title":"Genet Med sept"},{"key":"1600_CR23","doi-asserted-by":"publisher","first-page":"R150","DOI":"10.1093\/hmg\/ddaa127","volume":"29","author":"L Yehia","year":"2020","unstructured":"Yehia L, Eng C. PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation? Hum Mol Genet. 2020;29:R150\u20137.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1600_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ajhg.2015.10.001","volume":"97","author":"L Yehia","year":"2015","unstructured":"Yehia L, Niazi F, Ni Y, Ngeow J, Sankunny M, Liu Z, et al. Germline Heterozygous variants in SEC23B are associated with Cowden syndrome and enriched in apparently sporadic thyroid cancer. Am J Hum Genet. 2015;97(5):661\u201376.","journal-title":"Am J Hum Genet"},{"issue":"22","key":"1600_CR25","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1914919","volume":"382","author":"YR Lee","year":"2020","unstructured":"Lee YR, Yehia L, Kishikawa T, Ni Y, Leach B, Zhang J, et al. WWP1 Gain-of-function inactivation of PTEN in cancer predisposition. N Engl J Med. 2020;382(22):2103\u201316.","journal-title":"N Engl J Med"},{"key":"1600_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104360","volume":"64","author":"V Steinke-Lange","year":"2021","unstructured":"Steinke-Lange V, de Putter R, Holinski-Feder E, Claes KBM. Somatic mosaics in hereditary tumor predisposition syndromes. Eur J Med Genet. 2021;64: 104360.","journal-title":"Eur J Med Genet"},{"key":"1600_CR27","doi-asserted-by":"publisher","first-page":"6944","DOI":"10.1038\/s41598-018-25311-0","volume":"8","author":"C Theda","year":"2018","unstructured":"Theda C, Hwang SH, Czajko A, Loke YJ, Leong P, Craig JM. Quantitation of the cellular content of saliva and buccal swab samples. Sci Rep. 2018;8:6944. https:\/\/doi.org\/10.1038\/s41598-018-25311-0.","journal-title":"Sci Rep"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01600-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01600-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01600-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T19:31:50Z","timestamp":1702755110000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01600-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1600"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01600-0","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"assertion":[{"value":"14 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by local ethics committee (CPP Sud-Est VI Clermont-Ferrand); reference: IRB: 2022 \/ CE 42.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient give his written consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}